Jerry D. Johnson

Array ( [id] => 18792029 [patent_doc_number] => RE049735 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-11-28 [patent_title] => Oxazolidinones as modulators of MGLUR5 [patent_app_type] => reissue [patent_app_number] => 17/481947 [patent_app_country] => US [patent_app_date] => 2021-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54901 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17481947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19324205 [patent_doc_number] => RE050049 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-07-23 [patent_title] => Compositions and methods for treating psoriasis [patent_app_type] => reissue [patent_app_number] => 17/359639 [patent_app_country] => US [patent_app_date] => 2021-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 10984 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17359639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18699386 [patent_doc_number] => RE049699 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-10-17 [patent_title] => Inhibitors of TRPC6 [patent_app_type] => reissue [patent_app_number] => 17/334097 [patent_app_country] => US [patent_app_date] => 2021-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26108 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17334097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18340924 [patent_doc_number] => RE049518 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-05-02 [patent_title] => Fluorescent probe for detecting calpain activity [patent_app_type] => reissue [patent_app_number] => 17/327001 [patent_app_country] => US [patent_app_date] => 2021-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 23 [patent_no_of_words] => 5792 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18836236 [patent_doc_number] => RE049758 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-12-19 [patent_title] => Stabilised protein compositions based on semifluorinated alkanes [patent_app_type] => reissue [patent_app_number] => 17/155058 [patent_app_country] => US [patent_app_date] => 2021-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 7899 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17155058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18115657 [patent_doc_number] => RE049361 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-01-10 [patent_title] => Fused bicyclic (hetero)aromatic compounds useful for the treatment of cancers [patent_app_type] => reissue [patent_app_number] => 17/102621 [patent_app_country] => US [patent_app_date] => 2020-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21488 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 434 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17102621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18502985 [patent_doc_number] => RE049579 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-07-18 [patent_title] => Non-peptidic GAPDH aggregation inhibitor [patent_app_type] => reissue [patent_app_number] => 17/103444 [patent_app_country] => US [patent_app_date] => 2020-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 3236 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17103444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18288434 [patent_doc_number] => RE049481 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-04-04 [patent_title] => Compounds for the treatment and prophylaxis of respiratory syncytial virus disease [patent_app_type] => reissue [patent_app_number] => 17/075948 [patent_app_country] => US [patent_app_date] => 2020-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 97976 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17075948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18327668 [patent_doc_number] => RE049500 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-04-25 [patent_title] => Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto [patent_app_type] => reissue [patent_app_number] => 17/071566 [patent_app_country] => US [patent_app_date] => 2020-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15829 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17071566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18231546 [patent_doc_number] => RE049446 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-03-07 [patent_title] => Oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitors [patent_app_type] => reissue [patent_app_number] => 17/069940 [patent_app_country] => US [patent_app_date] => 2020-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26157 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17069940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17767534 [patent_doc_number] => RE049154 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2022-08-02 [patent_title] => Process for producing LPG and BTX [patent_app_type] => reissue [patent_app_number] => 17/061811 [patent_app_country] => US [patent_app_date] => 2020-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11240 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17061811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18231545 [patent_doc_number] => RE049445 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2023-03-07 [patent_title] => N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide [patent_app_type] => reissue [patent_app_number] => 17/013342 [patent_app_country] => US [patent_app_date] => 2020-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19184 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17013342 [rel_patent_id] =>[rel_patent_doc_number] =>)